In the News

TRHC’s Co-Founder and President Orsula V. Knowlton, PharmD, MBA Featured in Managed Healthcare Executive

Tabula Rasa HealthCare’s Co-Founder and President Orsula V. Knowlton, PharmD, MBA, was featured in the Managed Healthcare Executive article, “Eight Trends Expected to Shape Managed Care Pharmacy in 2020.”  The piece highlights the trends that experts expect will shape the pharmacy industry next year, including Knowlton’s perspective on pharmacists emerging as primary care providers.

TRHC’s Steven Gilbert Featured in Drug Topics

Steve Gilbert, MBA, RPh, BCPS, BCBG, CPHQ, Vice President, Performance Improvement, Tabula Rasa HealthCare was featured in the article “How to Train Staff on New Tech: Tips for Pharmacy Managers”  in the  November 19 issue of Drug Topics.  Access the PDF of Drug Topics.    

Talk To Your Pharmacist Podcast Featuring Jenny Bingham, PharmD, BCACP

In this episode, Jenny Bingham, PharmD, BCACP, discusses telepharmacy services. Dr. Jenny Bingham, is a Clinical Pharmacy Specialist at SinfoniaRx. Throughout her career, she has launched several novel programs aimed to improve the quality of care for patients in a variety of settings. She manages a transition of care program that has led to: reduced readmission rates at 30-, 60-, and 90-days post-discharge; decreased Medicare beneficiary expenditures; and a substantial return-on-investment. Dr. Bingham is committed... Read More

TRHC Founder and CEO Calvin H. Knowlton, BScPharm, MDiv, Ph.D. Featured in Pharmacy Times

Moorestown, NJ, November 1, 2019 – Tabula Rasa HealthCare Founder, Chairman and CEO Calvin H. Knowlton, Ph.D., participated in two news stories with Pharmacy Times; one video interview and one news article that focus on utilizing new technologies to reduce adverse drug events. The interviews took place during the National Community Pharmacist Association’s 2019 Annual Convention and Expo, October 26 – 29, in San Diego, California.   New Approaches Could Cut Adverse Drug Events https://www.pharmacytimes.com/conferences/ncpa-2019/new-approaches-could-cut-adverse-drug-events... Read More